The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
GANIRELIX SUN (Sun Pharma ANZ Pty Ltd)
Product name
GANIRELIX SUN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
146 working days (255)
Active ingredients
ganirelix acetate
Registration type
New generic medicine
Indication
GANIRELIX SUN (solution for injection) is indicated for the prevention of premature luteinisation and ovulation in patients undergoing controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques.